LLY posts 45% revenue growth to $65.2B in 2025 as GLP-1 drugs power results, and guides $80-$83B in sales with EPS up over 40 ...
Opinion
Zacks Investment Research on MSNOpinion
Top analyst reports for Eli Lilly, Marriott & Fortinet
Wednesday, February 11, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Eli ...
Zacks Investment Research on MSN
How to play Eli Lilly stock following a robust Q4 earnings report
Eli Lilly and Company LLY announced robust fourth-quarter results on Feb. 4. Lilly beat estimates for both earnings and sales and issued an upbeat guidance for 2026. Adjusted earnings per share of $7.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results